Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis.

Autor: Parker MJS; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Rheumatology Department, RPA Institute for Academic Medicine, Royal Prince Alfred Hospital, Sydney, Australia.; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, Australia., Jee AS; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, Australia.; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia., Hansen D; Department of Rheumatology, St Vincent's Hospital, Melbourne, Australia., Proudman S; Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia.; Discipline of Medicine, University of Adelaide, Adelaide, Australia., Youssef P; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Rheumatology Department, RPA Institute for Academic Medicine, Royal Prince Alfred Hospital, Sydney, Australia.; Institute for Musculoskeletal Health, Camperdown, Sydney, Australia., Kenna TJ; Centre for Immunology and Infection Control, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia., Stevens W; Department of Rheumatology, St Vincent's Hospital, Melbourne, Australia., Nikpour M; Department of Rheumatology, St Vincent's Hospital, Melbourne, Australia.; Department of Medicine, The University of Melbourne, Melbourne, Australia., Sahhar J; Department of Rheumatology, Monash Health, Melbourne, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia., Corte TJ; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, Australia.; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Nov 01; Vol. 63 (11), pp. 2981-2988.

Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.

Autor: Jee AS; Department of Respiratory, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia; National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Pulmonary Fibrosis, Australia. Electronic address: adelle.jee@health.nsw.gov.au., Parker MJS; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia; National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Pulmonary Fibrosis, Australia; Department of Rheumatology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. Electronic address: matthew.parker@health.nsw.gov.au., Bleasel JF; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia; Department of Rheumatology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. Electronic address: jane.bleasel@sydney.edu.au., Troy LK; Department of Respiratory, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia. Electronic address: ltroy@med.usyd.edu.au., Lau EM; Department of Respiratory, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia. Electronic address: edmundmtlau@gmail.com., Jo HE; Department of Respiratory, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia; National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Pulmonary Fibrosis, Australia. Electronic address: helen.jo@sydney.edu.au., Teoh AKY; Department of Respiratory, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia; National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Pulmonary Fibrosis, Australia. Electronic address: alan_tky@yahoo.com., Webster S; Department of Respiratory, Royal Prince Alfred Hospital, Sydney, NSW, Australia. Electronic address: susanne.webster@health.nsw.gov.au., Adelstein S; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia; Central Immunology Laboratory, NSW Health Pathology, NSW, Australia; Department of Clinical Immunology and Allergy, Royal Prince Alfred Hospital, NSW, Australia. Electronic address: stephen.adelstein@sydney.edu.au., Corte TJ; Department of Respiratory, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Central Clinical School, University of Sydney Faculty of Medicine and Health, Sydney, NSW, Australia; National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Pulmonary Fibrosis, Australia. Electronic address: tameracorte@me.com.

Publikováno v: Respiratory medicine [Respir Med] 2021 Oct; Vol. 187, pp. 106581. Date of Electronic Publication: 2021 Aug 21.

Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand.

Autor: Jee AS; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia., Sheehy R; Department of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, QLD, Australia.; School of Medicine, University of Queensland, Brisbane, QLD, Australia., Hopkins P; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; School of Medicine, University of Queensland, Brisbane, QLD, Australia.; Queensland Lung Transplant service, The Prince Charles Hospital, Brisbane, QLD, Australia., Corte TJ; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia., Grainge C; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; Department of Respiratory Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia., Troy LK; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia., Symons K; Department of Respiratory Medicine, Alfred Hospital, Melbourne, VIC, Australia., Spencer LM; Department of Physiotherapy, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Reynolds PN; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia.; Lung Research Laboratory, University of Adelaide, Adelaide, SA, Australia., Chapman S; Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia., de Boer S; Respiratory Services, Auckland District Health Board, Auckland, New Zealand., Reddy T; Department of Medical Imaging, The Prince Charles Hospital, Brisbane, QLD, Australia., Holland AE; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Monash University, Melbourne, VIC, Australia.; Department of Physiotherapy, Alfred Health, Melbourne, VIC, Australia.; Institute for Breathing and Sleep, Melbourne, VIC, Australia., Chambers DC; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; School of Medicine, University of Queensland, Brisbane, QLD, Australia.; Queensland Lung Transplant service, The Prince Charles Hospital, Brisbane, QLD, Australia., Glaspole IN; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; Department of Respiratory Medicine, Alfred Hospital, Melbourne, VIC, Australia.; Central Clinical School, Monash University, Melbourne, VIC, Australia., Jo HE; Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia., Bleasel JF; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; Department of Rheumatology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Wrobel JP; Advanced Lung Disease Unit, Fiona Stanley Hospital, Perth, WA, Australia.; Department of Medicine, University of Notre Dame Australia, Fremantle, WA, Australia., Dowman L; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Monash University, Melbourne, VIC, Australia.; Physiotherapy Department, Austin Health, Melbourne, VIC, Australia., Parker MJS; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; Department of Rheumatology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Wilsher ML; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; Respiratory Services, Auckland District Health Board, Auckland, New Zealand.; Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand., Goh NSL; Department of Respiratory Medicine, Alfred Hospital, Melbourne, VIC, Australia.; Institute for Breathing and Sleep, Melbourne, VIC, Australia.; Department of Respiratory Medicine, Austin Hospital, Melbourne, VIC, Australia.; Melbourne Medical School, University of Melbourne, Melbourne, VIC, Australia., Moodley Y; NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; University of Western Australia, Institute for Respiratory Health, Perth, WA, Australia.; Department of Respiratory Medicine, Fiona Stanley Hospital, Perth, WA, Australia., Keir GJ; Department of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, QLD, Australia.; School of Medicine, University of Queensland, Brisbane, QLD, Australia.

Publikováno v: Respirology (Carlton, Vic.) [Respirology] 2021 Jan; Vol. 26 (1), pp. 23-51. Date of Electronic Publication: 2020 Nov 24.

First risk, next reward? A new clinico-radiological risk model predicts mortality in rheumatoid arthritis-associated interstitial lung disease.

Autor: Parker MJS; Rheumatology Department, Institute of Rheumatology and Orthopaedics, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia., Corte TJ; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; Centre of Research Excellence in Pulmonary Fibrosis, Sydney, NSW, Australia.; Respiratory Department, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Publikováno v: Respirology (Carlton, Vic.) [Respirology] 2020 Dec; Vol. 25 (12), pp. 1225-1226. Date of Electronic Publication: 2020 Jul 30.

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.

Autor: Parker MJS; Rheumatology Department, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK.; Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.; Rheumatology Department, Institute of Rheumatology and Orthopaedics, Royal Prince Alfred Hospital, Sydney, Australia., Oldroyd A; Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Roberts ME; Manchester Academic Health Science Centre, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK., Lilleker JB; Manchester Academic Health Science Centre, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK., Betteridge ZE; Department of Pharmacy and Pharmacology, University of Bath, Bath, UK., McHugh NJ; Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.; Royal National Hospital for Rheumatic Disease, Bath, UK., Herrick AL; Rheumatology Department, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK.; Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Cooper RG; MRC-ARUK Centre for Integrated Research into Musculoskeletal Ageing, University of Liverpool, Liverpool, UK.; Centre for Integrated Genomic Medical Research, Division of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Chinoy H; Rheumatology Department, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK.; Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.; NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2019 Mar 01; Vol. 58 (3), pp. 468-475.